Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 168 (2) , 289-295
- https://doi.org/10.1016/s0021-9150(03)00094-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: